1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Cell Transformation, Neoplastic in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 21 (91.30) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chea, J; Colcher, D; Li, L; Liu, A; Miller, AD; Minnix, M; Poku, E; Rockne, RC; Shively, JE; Wong, JYC; Yazaki, PJ | 1 |
| Chen, CP; Gray, BD; Mattis, JA; Mehta, N; Mitchell, EP; Pak, KY; Paudyal, B; Thakur, ML; Wampole, ME; Wickstrom, E; Zhang, K | 1 |
| Arteaga de Murphy, C; Avila-Rodriguez, MA; Ferro-Flores, G; Gaspar-Carcamo, RE; Lopez-Rodriguez, V; Pedraza-Lopez, M; Rojas-Calderon, EL | 1 |
| Ji, S; Liu, S; Tomaselli, E; Yang, Y; Zheng, Y | 1 |
| Bowles, N; Channappa, D; Chea, J; Colcher, D; Crow, D; Delgado, MK; Li, L; Poku, E; Shively, JE; Szpikowska, B; Wong, JYC; Wong, P; Yazaki, PJ | 1 |
| Cai, W; Cao, F; Chen, K; Chen, X; Lee, A; Li, Z; Liu, Z; Wang, H; Wu, JC | 1 |
| Hansson, M; Orlova, A; Rosik, D; Sandström, M; Sjöberg, A; Tolmachev, V; Wållberg, H; Wennborg, A | 1 |
| Arano, Y; Fujibayashi, Y; Fukumura, T; Hino, O; Koizumi, M; Saga, T; Sogawa, C; Sudo, H; Sugyo, A; Tsuji, AB; Uehara, T; Yoshida, C; Yoshii, Y | 1 |
| Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
| Cescato, R; Fani, M; Maecke, HR; Mueller, A; Nicolas, G; Reubi, JC; Rink, HR; Tamma, ML | 1 |
| Bao, A; Cheng, Z; Cochran, JR; Culter, CS; Jiang, L; Kimura, RH; Li, P; Liu, H; Miao, Z | 1 |
| Dearling, JL; Dunning, P; Fahey, F; Huston, JS; Meares, CF; Packard, AB; Smith, SV; Snay, E; Treves, ST; Voss, SD | 1 |
| Bao, A; Cheng, Z; Hoppmann, S; Liu, H; Liu, S; Miao, Z; Ren, G | 1 |
| Baastrup, B; Feldwisch, J; Lindborg, M; Orlova, A; Sandström, M; Tolmachev, V | 1 |
| Capala, J; Choyke, P; Griffiths, GL; Kramer-Marek, G; Seidel, J; Shenoy, N | 1 |
| Kjaer, A; Madsen, J; Persson, M; Ploug, M; Østergaard, S | 1 |
| Abrahmsén, L; Bergman, T; Gräslund, T; Hofström, C; Malmberg, J; Orlova, A; Sandström, M; Sjöberg, A; Tolmachev, V | 1 |
| Jensen, MM; Juhl, K; Jørgensen, JT; Kjaer, A; Lehmann, C; Madsen, J; Persson, M; Ploug, M; Østergaard, S | 1 |
| Altai, M; Braun, A; Garske, U; Karlström, AE; Malmberg, J; Orlova, A; Perols, A; Sandström, M; Tolmachev, V; Varasteh, Z | 1 |
| Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P | 1 |
| Andersson, K; Gräslund, T; Hofström, C; Orlova, A; Sandstrom, M; Strand, J; Tolmachev, V; Varasteh, Z | 1 |
| Müller, C; Schibli, R; Struthers, H; Winiger, C; Zhernosekov, K | 1 |
| Chordia, MD; Chung, LW; Pan, D; Wang, JP; Xiao, L; Xie, X; Yue, W; Zhang, Y | 1 |
23 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Molecular Targeted Therapy; Ovarian Neoplasms; Radioimmunotherapy; Tissue Distribution | 2021 |
Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA.
Topics: Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Copper Radioisotopes; Doxorubicin; Female; Heterocyclic Compounds, 1-Ring; Humans; Insulin-Like Growth Factor I; Mice; Peptide Nucleic Acids; Positron-Emission Tomography; Receptor, ErbB-2; RNA, Messenger; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gallium Radioisotopes; Glioma; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Mice; Peptides, Cyclic; Positron-Emission Tomography; Radiochemistry; Radiometry; Radiopharmaceuticals; Rats; Tissue Distribution | 2015 |
Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dimerization; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Mice; Molecular Imaging; Peptides, Cyclic; Radiochemistry; Tissue Distribution | 2015 |
PET imaging of
Topics: Animals; Antigens, Surface; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Drug Carriers; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Nanoparticles; Positron-Emission Tomography; Prostatic Neoplasms; Single-Chain Antibodies | 2017 |
Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Embryonic Stem Cells; Endothelial Cells; Female; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Mice, Nude; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Transplantation, Heterologous | 2009 |
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Injections; Mice; Molecular Imaging; Neoplasms; Radioactive Tracers; Radionuclide Imaging; Recombinant Fusion Proteins; Substrate Specificity; Tissue Distribution | 2010 |
Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Indium Radioisotopes; Iodine Radioisotopes; Membrane Glycoproteins; Mesothelin; Mesothelioma; Mice; Mice, Inbred BALB C; Positron-Emission Tomography | 2010 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
Topics: Animals; Calcium; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cricetulus; Drug Design; Enzyme Stability; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Protein Transport; Radioactive Tracers; Radiography; Receptors, Somatostatin; Somatostatin; Structure-Activity Relationship; Tomography, Emission-Computed, Single-Photon | 2010 |
Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.
Topics: Adult; Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Cystine-Knot Miniproteins; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Integrins; Lutetium; Male; Mice; Models, Molecular; Molecular Sequence Data; Platelet Membrane Glycoproteins; Protein Conformation; Radiation Dosage; Radiochemistry; Radioisotopes; Radiotherapy | 2011 |
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
Topics: Aniline Compounds; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Copper Radioisotopes; Cross-Linking Reagents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Melanoma; Mice; Positron-Emission Tomography | 2011 |
Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Female; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Models, Molecular; Molecular Weight; Ovarian Neoplasms; Positron-Emission Tomography; Protein Conformation; Protein Transport; Radiochemistry; Radiometry; Receptor, ErbB-2; Recombinant Fusion Proteins; Serum Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate.
Topics: Amino Acid Sequence; Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Molecular Sequence Data; Ovarian Neoplasms; Peptides; Radionuclide Imaging; Recombinant Fusion Proteins | 2011 |
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Mice; Multimodal Imaging; Positron-Emission Tomography; Receptor, ErbB-2; Recombinant Fusion Proteins; Tomography, X-Ray Computed | 2011 |
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Topics: Acetates; Amides; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Drug Stability; Female; Gallium; Gallium Radioisotopes; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasm Invasiveness; Peptides; Positron-Emission Tomography; Protein Binding; Receptors, Urokinase Plasminogen Activator | 2012 |
Imaging of insulinlike growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule 111In-DOTA-ZIGF1R:4551.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Feasibility Studies; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Mice; Prostatic Neoplasms; Radionuclide Imaging; Receptor, IGF Type 1; Recombinant Fusion Proteins | 2012 |
Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion.
Topics: Animals; Cell Transformation, Neoplastic; Colorectal Neoplasms; Copper Radioisotopes; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Mice; Multimodal Imaging; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radiochemistry; Receptors, Urokinase Plasminogen Activator; Tomography, X-Ray Computed | 2012 |
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.
Topics: Acetates; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Male; Mice; Molecular Imaging; Molecular Sequence Data; Prostatic Neoplasms; Receptor, ErbB-2; Substrate Specificity | 2012 |
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity | 2012 |
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Prostatic Neoplasms; Radionuclide Imaging; Receptor, IGF Type 1; Recombinant Fusion Proteins; Technetium | 2013 |
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Topics: Albumins; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Folic Acid; Heterocyclic Compounds, 1-Ring; Humans; KB Cells; Lutetium; Mice; Molecular Targeted Therapy; Multimodal Imaging; Positron-Emission Tomography; Radioisotopes; Tomography, X-Ray Computed | 2013 |
Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.
Topics: Animals; Biological Transport; Breast Neoplasms; Carbocyanines; Cell Transformation, Neoplastic; Chemistry Techniques, Synthetic; Copper Radioisotopes; Female; Heterocyclic Compounds, 1-Ring; Humans; MCF-7 Cells; Mice; Positron-Emission Tomography; Spectrometry, Fluorescence; Tumor Burden | 2013 |